Perspective Therapeutics, Inc. 8-K

What Happened

• Perspective Therapeutics, Inc. filed a Current Report on Form 8-K on July 1, 2026 (Items 8.01 and 9.01) to disclose an updated corporate presentation.
• The presentation was filed as Exhibit 99.1 and is incorporated by reference into the 8-K. The form was signed by Joel Sendek, Chief Financial Officer, on July 1, 2026.
• The filing does not include earnings, revenue figures, executive changes (other than the signature), mergers, acquisitions, or other financial statements.

Key Details

• Filing date: July 1, 2026.
• Exhibit: 99.1 — Corporate Presentation (updated).
• Reporting items: Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
• Signature: Joel Sendek, Chief Financial Officer, signed the filing on behalf of the company.

Why It Matters

• The update provides investors with the company’s latest investor-facing materials (strategy, pipeline, or corporate overview) in one accessible document.
• Because no financial results or material corporate actions were reported in this 8-K, investors should treat this as an information update rather than a disclosure of new financial performance or management changes.
• Investors seeking detail should review the filed Exhibit 99.1 presentation directly for any changes to guidance, strategy, pipeline milestones, or capital plans.